An official ATS/AACN/ACCP/ESICM/SCCM policy statement: responding to requests for potentially inappropriate treatments in Intensive Care Units

by jmiller on July 16, 2015

“The multisociety statement on responding to requests for potentially inappropriate treatments in intensive care units provides guidance for clinicians to prevent and manage disputes in patients with advanced critical illness.”   (Am J Resp Crit Care Med, June 1)   Click here learn more

How slow is too slow? Correlation of operative time to complications? An analysis from the Tennessee Surgical Quality Collaborative

by jmiller on July 16, 2015

“Duration of operation correlates with complications and time longer than a statewide established standard carries higher risk.  to reduce risk of complications, these data support expeditious surgical technique and preoperative pulmonary training, and offer accurate outcomes assessment for patient counseling … learn more

Breast cancer screening, incidence, and mortality across US counties

by jmiller on July 16, 2015

“When analyzed at the county level, the clearest result of mammography screening is the diagnosis of additional small cancers.  Furthermore, there is no conocomitant decline in the detection of larger cancers, which might explain the absence of any significant difference … learn more

Edoxaban (Savaysa) – The Fourth New Oral Anticoagulant

by jmiller on July 16, 2015

“The FDA has approved edoxaban (Savaysa), a once-daily, oral, direct factor Xa inhibitor, for treatment of venous thromboembolism (VTE) and for prevention of stroke and systematic embolism in patients with nonvalvular atrial fibrillation.  It is the fourth new oral anticoagulant … learn more

NEW DATABASE – Used in conjunction with UpToDate – VisualDX

by jmiller on July 9, 2015

What is VisualDx?

VisualDx is one of the most widely used medical apps in the world to improve diagnostic accuracy,  medical education  and patient education.   VisualDx is already licensed by more than 50% of US medical schools including Harvard, Yale, … learn more

Innovation in maternal-fetal therapy: a positon statement of the NA Fetal Therapy Network and Expanded carrier screening in reproductive medicine – points to consider: A joint statement

by jmiller on June 26, 2015

Innovative medical therapy often occupies an uncomfortable space between formal research and established clinical practice..  Because fetal medicine is unique in that other fields do not have to consider the well being of two individuals at the same time, the … learn more

ACOG Practice Bulletin148: Thyroid disease in pregnancy and ACOG Practice Bulletin 149: Endometrial Cancer

by jmiller on June 26, 2015

ACOG issued two new Practice Bulletins  (Obstet Gynecol, April) .  The thyroid bulletin expresses concerns over uncontrolled thyrotoxicosis and hypothyroidism having adverse pregnancy outcomes. It also impacts fetal development.  In addition, medications that affect the maternal thyroid gland can cross … learn more

An official ATS/AACN/ACCP/ESICMSCCM Policy Statement: Responding to requests for potentially inappropriate treatments in Intensive Care Units

by jmiller on June 25, 2015

Concludes:  “The multisociety statement on responding to requests for potentially inapproprate treatments in intensive care units provides guidance for clinicians to prevent and manage disputes in patients with advanced critical illness.“  Am J Resp Crit Care Med, June 1)  learn more

Older posts «